189 related articles for article (PubMed ID: 22204484)
1. Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents.
Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
Curr Top Med Chem; 2012; 12(4):286-311. PubMed ID: 22204484
[TBL] [Abstract][Full Text] [Related]
2. Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects.
Simorini F; Marini AM; Taliani S; La Motta C; Salerno S; Pugliesi I; Da Settimo F
Curr Top Med Chem; 2012; 12(4):333-51. PubMed ID: 22204487
[TBL] [Abstract][Full Text] [Related]
3. Geometrically constrained derivatives of indolylglyoxylamides as ligands binding the GABAA/BzR complex.
Sartini S; Morelli M; Simorini F; Taliani S; Salerno S; Marini AM; Da Settimo F; La Motta C
Curr Top Med Chem; 2012; 12(4):312-20. PubMed ID: 22204489
[TBL] [Abstract][Full Text] [Related]
4. From the pharmacophore to the homology model of the benzodiazepine receptor: the indolyglyoxylamides affair.
Cosimelli B; Cosconati S; Marinelli L; Novellino E; Greco G
Curr Top Med Chem; 2012; 12(4):321-32. PubMed ID: 22204482
[TBL] [Abstract][Full Text] [Related]
5. The GABAA-BZR complex as target for the development of anxiolytic drugs.
Trincavelli ML; Da Pozzo E; Daniele S; Martini C
Curr Top Med Chem; 2012; 12(4):254-69. PubMed ID: 22204488
[TBL] [Abstract][Full Text] [Related]
6. Novel N-(arylalkyl)indol-3-ylglyoxylylamides targeted as ligands of the benzodiazepine receptor: synthesis, biological evaluation, and molecular modeling analysis of the structure-activity relationships.
Primofiore G; Settimo FD; Taliani S; Marini AM; Novellino E; Greco G; Lavecchia A; Besnard F; Trincavelli L; Costa B; Martini C
J Med Chem; 2001 Jul; 44(14):2286-97. PubMed ID: 11428922
[TBL] [Abstract][Full Text] [Related]
7. Recent developments in potential anxiolytic agents targeting GABAA/BzR complex or the translocator protein (18kDa) (TSPO).
Nothdurfter C; Rupprecht R; Rammes G
Curr Top Med Chem; 2012; 12(4):360-70. PubMed ID: 22204486
[TBL] [Abstract][Full Text] [Related]
8. Ligands for the benzodiazepine binding site--a survey.
Teuber L; Wätjens F; Jensen LH
Curr Pharm Des; 1999 May; 5(5):317-43. PubMed ID: 10213798
[TBL] [Abstract][Full Text] [Related]
9. Identification of anxiolytic/nonsedative agents among indol-3-ylglyoxylamides acting as functionally selective agonists at the gamma-aminobutyric acid-A (GABAA) alpha2 benzodiazepine receptor.
Taliani S; Cosimelli B; Da Settimo F; Marini AM; La Motta C; Simorini F; Salerno S; Novellino E; Greco G; Cosconati S; Marinelli L; Salvetti F; L'Abbate G; Trasciatti S; Montali M; Costa B; Martini C
J Med Chem; 2009 Jun; 52(12):3723-34. PubMed ID: 19469479
[TBL] [Abstract][Full Text] [Related]
10. Computational studies on translocator protein (TSPO) and its ligands.
Ortore G; Tuccinardi T; Martinelli A
Curr Top Med Chem; 2012; 12(4):352-9. PubMed ID: 22204485
[TBL] [Abstract][Full Text] [Related]
11. Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1/L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-selective ligands.
Primofiore G; Taliani S; Da Settimo F; Marini AM; La Motta C; Simorini F; Patrizi MP; Sergianni V; Novellino E; Greco G; Cosimelli B; Calderone V; Montali M; Besnard F; Martini C
J Med Chem; 2007 Apr; 50(7):1627-34. PubMed ID: 17335185
[TBL] [Abstract][Full Text] [Related]
12. Structure-Dependent Activity of Natural GABA(A) Receptor Modulators.
Çiçek SS
Molecules; 2018 Jun; 23(7):. PubMed ID: 29932138
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors.
Cox ED; Diaz-Arauzo H; Huang Q; Reddy MS; Ma C; Harris B; McKernan R; Skolnick P; Cook JM
J Med Chem; 1998 Jul; 41(14):2537-52. PubMed ID: 9651158
[TBL] [Abstract][Full Text] [Related]
14. GABA A/Bz receptor subtypes as targets for selective drugs.
Da Settimo F; Taliani S; Trincavelli ML; Montali M; Martini C
Curr Med Chem; 2007; 14(25):2680-701. PubMed ID: 17979718
[TBL] [Abstract][Full Text] [Related]
15. Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site.
Atack JR
Curr Drug Targets CNS Neurol Disord; 2003 Aug; 2(4):213-32. PubMed ID: 12871032
[TBL] [Abstract][Full Text] [Related]
16. The indolylglyoxylamide scaffold as an useful tool to obtain anxiolytic agents.
Taliani S; Da Settimo F
Curr Top Med Chem; 2012; 12(4):236-7. PubMed ID: 22204480
[No Abstract] [Full Text] [Related]
17. Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligands.
Richter L; de Graaf C; Sieghart W; Varagic Z; Mörzinger M; de Esch IJ; Ecker GF; Ernst M
Nat Chem Biol; 2012 Mar; 8(5):455-64. PubMed ID: 22446838
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiology of benzodiazepine receptor ligands: multiple mechanisms and sites of action.
Polc P
Prog Neurobiol; 1988; 31(5):349-423. PubMed ID: 2851856
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse.
Yin W; Majumder S; Clayton T; Petrou S; VanLinn ML; Namjoshi OA; Ma C; Cromer BA; Roth BL; Platt DM; Cook JM
Bioorg Med Chem; 2010 Nov; 18(21):7548-64. PubMed ID: 20888240
[TBL] [Abstract][Full Text] [Related]
20. Benzodiazepines.
Haefely WE
Int Anesthesiol Clin; 1988; 26(4):262-72. PubMed ID: 2461909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
